TrialThe Journal of clinical endocrinology and metabolism2014

The effects of tesamorelin on phosphocreatine recovery in obese subjects with reduced GH.

Hideo Makimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.